Highland Capital Management LP lowered its stake in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 48.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 13,000 shares of the medical device company’s stock after selling 12,000 shares during the period. Highland Capital Management LP’s holdings in Cooper Companies, Inc. (The) were worth $2,274,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of COO. Mitsubishi UFJ Trust & Banking Corp boosted its stake in shares of Cooper Companies, Inc. (The) by 3.0% in the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 135,927 shares of the medical device company’s stock valued at $24,366,000 after buying an additional 3,923 shares during the last quarter. Northern Trust Corp boosted its stake in shares of Cooper Companies, Inc. (The) by 17.3% in the third quarter. Northern Trust Corp now owns 628,662 shares of the medical device company’s stock valued at $112,694,000 after buying an additional 92,823 shares during the last quarter. Oak Ridge Investments LLC boosted its stake in shares of Cooper Companies, Inc. (The) by 19.2% in the third quarter. Oak Ridge Investments LLC now owns 20,988 shares of the medical device company’s stock valued at $3,762,000 after buying an additional 3,386 shares during the last quarter. Bank of Montreal Can boosted its stake in shares of Cooper Companies, Inc. (The) by 80.9% in the third quarter. Bank of Montreal Can now owns 25,253 shares of the medical device company’s stock valued at $4,527,000 after buying an additional 11,291 shares during the last quarter. Finally, Motley Fool Wealth Management LLC boosted its stake in shares of Cooper Companies, Inc. (The) by 3.3% in the fourth quarter. Motley Fool Wealth Management LLC now owns 24,709 shares of the medical device company’s stock valued at $4,322,000 after buying an additional 794 shares during the last quarter. Institutional investors own 97.44% of the company’s stock.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Cooper Companies, Inc. (NYSE:COO) traded down 0.42% during mid-day trading on Thursday, hitting $190.51. 422,327 shares of the company were exchanged. The company has a market capitalization of $9.29 billion, a P/E ratio of 34.08 and a beta of 0.56. The company’s 50-day moving average is $182.62 and its 200 day moving average is $179.50. Cooper Companies, Inc. has a 12-month low of $138.17 and a 12-month high of $192.38.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its earnings results on Thursday, December 8th. The medical device company reported $2.28 earnings per share for the quarter, beating analysts’ consensus estimates of $2.25 by $0.03. Cooper Companies, Inc. (The) had a net margin of 13.93% and a return on equity of 15.38%. The firm had revenue of $518.70 million for the quarter. Analysts expect that Cooper Companies, Inc. will post $9.21 EPS for the current year.

The business also recently announced a semiannual dividend, which was paid on Thursday, February 9th. Shareholders of record on Monday, January 23rd were given a $0.03 dividend. The ex-dividend date of this dividend was Thursday, January 19th. This represents a yield of 0.03%. Cooper Companies, Inc. (The)’s dividend payout ratio is currently 1.07%.

This article was posted by Watch List News and is owned by of Watch List News. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The correct version of this article can be viewed at http://www.watchlistnews.com/highland-capital-management-lp-sells-12000-shares-of-cooper-companies-inc-the-coo/1120603.html.

COO has been the subject of several recent research reports. Wells Fargo & Company upgraded shares of Cooper Companies, Inc. (The) from a “market perform” rating to an “outperform” rating in a research report on Monday, December 12th. Zacks Investment Research cut shares of Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a research report on Monday, November 21st. BMO Capital Markets set a $203.00 target price on shares of Cooper Companies, Inc. (The) and gave the company a “buy” rating in a research report on Friday, December 9th. Oppenheimer Holdings, Inc. set a $188.00 target price on shares of Cooper Companies, Inc. (The) and gave the company a “hold” rating in a research report on Friday, December 9th. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $210.00 target price on shares of Cooper Companies, Inc. (The) in a research report on Wednesday, December 7th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Cooper Companies, Inc. (The) presently has an average rating of “Buy” and a consensus target price of $203.63.

In other news, Director Gary S. Petersmeyer sold 458 shares of Cooper Companies, Inc. (The) stock in a transaction on Thursday, January 5th. The shares were sold at an average price of $175.97, for a total transaction of $80,594.26. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Daniel G. Mcbride sold 20,000 shares of Cooper Companies, Inc. (The) stock in a transaction on Tuesday, December 20th. The stock was sold at an average price of $174.82, for a total transaction of $3,496,400.00. Following the transaction, the chief operating officer now owns 43,644 shares in the company, valued at approximately $7,629,844.08. The disclosure for this sale can be found here. Insiders sold 39,408 shares of company stock worth $6,925,164 in the last 90 days. Company insiders own 1.60% of the company’s stock.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

5 Day Chart for NYSE:COO

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.